[Optimizing current drugs].
Blay
J-Y
JY
Unité Inserm 590, Centre Léon Bérard F69008 Lyon, France; Hôpital Edouard Herriot, Place d'Arsonval, F69003 Lyon., France. blay@fnclcc.lyon.fr
D000970:Antineoplastic Agents / Q000266:history / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001549:Benzamides; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D000068877:Imatinib Mesylate; D009369:Neoplasms / Q000188:drug therapy* / Q000266:history; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D002166:Camptothecin